Industry News
HPV Vaccine Less Likely To Be Recommend By Pediatricians In Appalachia
Sep 29, 2011
Pediatricians in Appalachia are less likely than doctors in other areas to encourage parents to have their children receive the human papillomavirus (HPV) vaccine, according to a new study... Read More
Finding Of Gene Fusion In Ovarian Cancer Could Help Understanding Of How Deadly Tumors Develop And Spread
Sep 26, 2011
A study published in the September 20 issue of the online open-access journal PLoS Biology reveals that researchers discovered, during their study of ovarian cancer, that a substantial number of ovarian tumors show a gene that is closely related to the estrogen receptor. The gene is broken and fused to an adjacent gene by a chromosome rearrangement... Read More
New Data Suggest OncoHealth's HPV E6 And E7 Tests Can Distinguish Cervical Disease From Clinically Insignificant HPV Infection
Sep 22, 2011
OncoHealth Corporation, a protein biomarker diagnostics company, announced new study data showing that the company's proprietary HPV E6 and E7 oncoprotein assays correlated with cervical disease grade and may distinguish cervical disease or cervical cancer from clinically insignificant HPV infection... Read More
First Recurrent Gene Fusion Identified In Ovarian Cancer
Sep 22, 2011
Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by a chromosome rearrangement; a finding that could shed light on how these deadly tumors develop and spread... Read More
New Imaging Technique Highlights Cancer During Surgery
Sep 21, 2011
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis... Read More
First Fluorescence-Guided Ovarian Cancer Surgery
Sep 20, 2011
The first fluorescence-guided surgery on an ovarian cancer patient was performed using a cancer cell "homing device" and imaging agent created by a Purdue University researcher. The surgery was one of 10 performed as part of the first phase of a clinical trial to evaluate a new technology to aid surgeons in the removal of malignant tissue from ovarian cancer patients... Read More
Fluorescent Dye Lights Up Cancer Cells Making Surgery More Effective
Sep 19, 2011
A tumor-specific fluorescent dye and an ultra-sensitive camera system used during surgery can help surgeons identify difficult-to-spot cancers. Surgeons at the University Medical Center, Groningen, the Netherlands, have used this technique for the first time on women with ovarian cancer... Read More
Utilizing A Virus As A Potential Future Cancer Medicine
Sep 19, 2011
In a new project, researchers from LIFE - the Faculty of Life Sciences at the University of Copenhagen - document that the vesicular stomatitis virus (VSV) plays a previously unknown dual role in the prevention of a number of cancers... Read More
Experts Urge Women To Recognize Warning Signs For Ovarian Cancer; Receive Appropriate Screenings
Sep 19, 2011
Ovarian cancer is a rare but often deadly disease that can strike at any time in a woman's life. It affects one in 70 women and in the past was referred to as a silent killer, but researchers have found there are symptoms associated with ovarian cancer that can assist in early detection... Read More
Researchers Find Possible Key To Preventing Chemotherapy Resistance In Ovarian Cancer
Sep 18, 2011
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution of chemotherapy resistance... Read More
Previous Page Next Page